
Tong Ren Tang Technologies Co. Ltd.
1666.HKHKSEHealthcareDrug Manufacturers - General
Latest quote
HK$3.19
−HK$0.10 · -3.04%
1666.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteTong Ren Tang Technologies Co. Ltd., a company founded in 1669 and based in Beijing, People's Republic of China, maintains extensive operations across Mainland China and Hong Kong. Its primary activities center on the manufacturing and sale of traditional Chinese medicine products. The company's involvement is comprehensive, extending to the cultivation, sourcing, and distribution of Chinese medicinal raw materials. Beyond its core offerings, Tong Ren Tang diversifies its product portfolio with items such as ointments, tea beverages, and specialized foot care solutions. The enterprise is also active in the technological advancement and commercialization of biological products, alongside Western pharmaceuticals, cosmetics, and general healthcare goods. Its distribution network includes both wholesale and retail channels for Chinese medicines and health-related products. Furthermore, Tong Ren Tang provides a broad spectrum of services, including medical research and development, Chinese medical consultation and treatment, advertising, internal and external surgical procedures, medical examinations, and hospital management. Additionally, the company engages in the processing of biochemical products, plant extraction, and the production of various food and daily chemical items.
- Industry
- Drug Manufacturers - General
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Chun You Zhang
- Listed since
- Oct 31, 2000
- Employees
- 3,951
Market position
Day range
Current HK$3.19
52-week range
Current HK$3.19
- Open
- HK$3.29
- Previous close
- HK$3.29
- Volume
- 1.06M
- 0.88× average
- Average volume
- 1.2M
- Average daily volume
- Market cap
- 4.09B HKD
- Beta
- 0.79
- Market reference 1
- 50-day average
- HK$3.3813
- -5.66% below average
- 200-day average
- HK$4.0073
- -20.40% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.54B CNY
- P/E (TTM)
- 8.97×
- P/B (TTM)
- 0.48×
- P/S (TTM)
- 0.54×
- EV / EBITDA
- 2.53×
- Earnings yield
- 7.81%
- Free cash flow yield
- 28.49%
- Dividend yield
- 6.49%
Profitability & efficiency
- Gross margin
- 38.03%
- Operating margin
- 12.37%
- Net margin
- 6.11%
- Return on equity
- 5.40%
- Return on assets
- 2.89%
- Return on invested capital
- 5.20%
Financial health
- Debt / equity
- 0.3×
- Current ratio
- 5.72×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.48B CNY | 7.26B CNY | 6.77B CNY | 5.99B CNY | 5.4B CNY |
| Cost of goods sold | 4.02B CNY | 4.38B CNY | 3.93B CNY | 3.4B CNY | 3.11B CNY |
| Gross profit | 2.47B CNY | 2.88B CNY | 2.85B CNY | 2.59B CNY | 2.29B CNY |
| Research and development | 82.76M CNY | 84.82M CNY | 117.56M CNY | 78.43M CNY | 48.9M CNY |
| Selling, general, and administrative | 1.6B CNY | 1.89B CNY | 1.71B CNY | 1.39B CNY | 1.21B CNY |
| Operating expenses | 1.66B CNY | 1.89B CNY | 1.73B CNY | 1.38B CNY | 1.21B CNY |
| Interest income | 68.94M CNY | 76.23M CNY | 91.13M CNY | 44.22M CNY | 28.05M CNY |
| Interest expense | 59.07M CNY | 64.46M CNY | 45.05M CNY | 53.8M CNY | 61.8M CNY |
| Depreciation and amortization | 199.07M CNY | 186.11M CNY | 186.11M CNY | 179.21M CNY | 175.88M CNY |
| Operating income | 802.14M CNY | 985.16M CNY | 1.12B CNY | 1.21B CNY | 1.08B CNY |
| Net income | 396.28M CNY | 521.8M CNY | 590.19M CNY | 582.89M CNY | 507.25M CNY |
Company facts updated Aug 24, 2026.
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.1966
2025 complete year+1.1% since 2021
2026 partial: HK$0.2069
HK$0.1945
2,021
HK$0.1869
2,022
HK$0.1758
2,023
HK$0.1978
2,024
HK$0.1966
2,025
HK$0.2069
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jun 16, 2026 | HK$0.2069Annual | Jun 17, 2026 | Aug 11, 2026 |
Dividend | Jun 16, 2025 | HK$0.1966Annual | Jun 17, 2025 | Aug 11, 2025 |
Dividend | Jun 14, 2024 | HK$0.1978Annual | Jun 17, 2024 | Aug 9, 2024 |
Dividend | Jun 19, 2023 | HK$0.1758Annual | Jun 20, 2023 | Aug 14, 2023 |
Dividend | Jun 20, 2022 | HK$0.1869Annual | Jun 21, 2022 | Aug 15, 2022 |
Dividend | Jun 10, 2021 | HK$0.1945Annual | Jun 11, 2021 | Aug 5, 2021 |
Ex-dividend Jun 16, 2026
HK$0.2069
Annual
Record Jun 17, 2026 · Payment Aug 11, 2026
Ex-dividend Jun 16, 2025
HK$0.1966
Annual
Record Jun 17, 2025 · Payment Aug 11, 2025
Ex-dividend Jun 14, 2024
HK$0.1978
Annual
Record Jun 17, 2024 · Payment Aug 9, 2024
Ex-dividend Jun 19, 2023
HK$0.1758
Annual
Record Jun 20, 2023 · Payment Aug 14, 2023
Ex-dividend Jun 20, 2022
HK$0.1869
Annual
Record Jun 21, 2022 · Payment Aug 15, 2022
Ex-dividend Jun 10, 2021
HK$0.1945
Annual
Record Jun 11, 2021 · Payment Aug 5, 2021
1666.HK peers
Continue in GoAI
Research 1666.HKresearch.disclaimer





